Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 20;6(4):BJGPO.2022.0048.
doi: 10.3399/BJGPO.2022.0048. Print 2022 Dec.

Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study

Charis Xuan Xie  1 , John Robson  2 , Crystal Williams  2 , Chris Carvalho  1   2 , Stuart Rison  1   2 , Zahra Raisi-Estabragh  3   4
Affiliations

Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study

Charis Xuan Xie et al. BJGP Open. .

Abstract

Background: Patients with both atrial fibrillation (AF) and cardiovascular disease (CVD) may receive dual antithrombotic therapy (DAT) with both an anticoagulant and ≥1 antiplatelet agents. Avoiding prolonged duration of DAT and use of gastroprotective therapies reduces bleeding risk.

Aim: To describe the extent and duration of DAT and use of gastroprotection in a primary care cohort of patients with AF.

Design & setting: Observational study in 1.2 million people registered with GPs across four east London clinical commissioning groups (CCGs), covering prescribing from January 2020-June 2021.

Method: In patients with AF, factors associated with DAT prescription, prolonged DAT prescription (>12 months), and gastroprotective prescription were characterised using logistic regression.

Results: There were 8881 patients with AF, of whom 4.7% (n = 416) were on DAT. Of these, 65.9% (n = 274) were prescribed DAT for >12 months and 84.4% (n = 351) were prescribed concomitant gastroprotection. Independent of all other factors, females with AF were less likely to receive DAT than males (odds ratio [OR] 0.61, 95% confidence interval [CI] = 0.49 to 0.77). Similarly, older (aged ≥75 years) individuals (OR 0.79, 95% CI = 0.63 to 0.98) were less likely to receive DAT than younger patients. Among those with AF on DAT, pre-existing CVD (OR 3.33, 95% CI = 1.71 to 6.47) and South Asian ethnicity (OR 2.70, 95% CI = 1.15 to 6.32) were associated with increased gastroprotection prescriptions. Gastroprotection prescription (OR 1.80, 95% CI = 1.01 to 3.22) was associated with prolonged DAT prescription.

Conclusion: Almost two-thirds of patients with AF on DAT were prescribed prolonged durations of therapy. Prescription of gastroprotection therapies was suboptimal in one in six patients. Treatment decisions varied by sex, age, ethnic group, and comorbidity. Duration of DAT and gastroprotection in patients with AF requires improvement.

Keywords: anticoagulation; antiplatelets; atrial fibrillation; bleeding risk; cardiovascular diseases; dual antithrombin therapy; gastroprotection; population health.

PubMed Disclaimer

References

    1. World Health Organization Global health and aging. 2011. https://www.nia.nih.gov/sites/default/files/2017-06/global_health_aging.pdf. [13 Sep 2022]. https://www.nia.nih.gov/sites/default/files/2017-06/global_health_aging.pdf accessed.
    1. Yarnall AJ, Sayer AA, Clegg A, et al. New horizons in multimorbidity in older adults. Age Ageing. 2017; 46 (6):882–888. doi: 10.1093/ageing/afx150. - DOI - PMC - PubMed
    1. Roth GA, Abate D, Abate KH, Abay SM. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392 (10159):1736–1788. doi: 10.1016/S0140-6736(18)32203-7. - DOI - PMC - PubMed
    1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42 (5):373–498. doi: 10.1093/eurheartj/ehaa612. - DOI - PubMed
    1. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41 (3):407–477. - PubMed

LinkOut - more resources